Correlation Between Merck and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both Merck and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Organogenesis Holdings, you can compare the effects of market volatilities on Merck and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Organogenesis Holdings.
Diversification Opportunities for Merck and Organogenesis Holdings
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Merck and Organogenesis is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Merck i.e., Merck and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between Merck and Organogenesis Holdings
Considering the 90-day investment horizon Merck Company is expected to under-perform the Organogenesis Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 3.41 times less risky than Organogenesis Holdings. The stock trades about -0.07 of its potential returns per unit of risk. The Organogenesis Holdings is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 318.00 in Organogenesis Holdings on October 23, 2024 and sell it today you would earn a total of 16.00 from holding Organogenesis Holdings or generate 5.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Merck Company vs. Organogenesis Holdings
Performance |
| Timeline |
| Merck Company |
| Organogenesis Holdings |
Merck and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and Organogenesis Holdings
The main advantage of trading using opposite Merck and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.| Merck vs. DiaMedica Therapeutics | Merck vs. Seres Therapeutics | Merck vs. Inhibikase Therapeutics | Merck vs. Oncolytics Biotech |
| Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |